Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2025-12-24 @ 3:45 PM
NCT ID:
NCT00469092
Eligibility Criteria:
Inclusion Criteria:
* Type 2 diabetes
* Treatment with OADs (Oral Anti-Diabetic Drugs) for more than 6 months
* Ongoing stable treatment with metformin for at least 2 months
* Ongoing stable treatment with minimum half maximal dose of any insulin secretagogue for at least 2 months
* Insulin naive
* HbA1c (glycosylated haemoglobin A1c) between 7.0% and 11.0% (inclusive of both values)
Exclusion Criteria:
* Metformin contraindication according to local practice
* TZD (thiazolidinedione) treatment for the last 5 months before trial start
* Systemic treatment with any corticosteroid 3 months before trial start
* Any disease or condition which according to the Investigator would interfere with the trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00469092
Study Brief:
Protocol Section:
NCT00469092